Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Daniel R. Knight"'
Autor:
Haitham Hussain, Amer Nubgan, César Rodríguez, Korakrit Imwattana, Daniel R. Knight, Valerija Parthala, Peter Mullany, Shan Goh
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Clostridioides difficile is an emerging pathogen of One Health significance. Its highly variable genome contains mobile genetic elements (MGEs) such as transposons and prophages that influence its biology. Systematic deletion of each genetic element
Externí odkaz:
https://doaj.org/article/5a31a494606f40a49add97498e7cd619
Autor:
Jake Gazeley, Terence Lee, Daniel R. Knight, Alexander Shivarev, Cameron Gordon, David Speers, Dylan D. Barth, Jelena Maticevic, Meredith Hodge, Paul Armstrong, Paul Knight, Sandra Sjollema, Avram Levy
Publikováno v:
Environments, Vol 11, Iss 4, p 62 (2024)
Wastewater-based epidemiology (WBE) has emerged as a key method for the continuous monitoring of COVID-19 prevalence including circulating SARS-CoV-2 lineages. WBE addresses the limitations of traditional clinical COVID-19 surveillance such as clinic
Externí odkaz:
https://doaj.org/article/fd5610c8aede48f0a6cd5e7bac158621
Autor:
Noel P. Pitcher, Jitendra R. Harjani, Yichao Zhao, Jianwen Jin, Daniel R. Knight, Lucy Li, Papanin Putsathit, Thomas V. Riley, Glen P. Carter, Jonathan B. Baell
Publikováno v:
ACS Omega, Vol 7, Iss 8, Pp 6737-6759 (2022)
Externí odkaz:
https://doaj.org/article/2cb2c9b176f449c28e66dba1e8d0cf30
Publikováno v:
Microorganisms, Vol 11, Iss 7, p 1743 (2023)
Clostridioides difficile poses an ongoing threat as a cause of gastrointestinal disease in humans and animals. Traditionally considered a human healthcare-related disease, increases in community-associated C. difficile infection (CDI) and growing evi
Externí odkaz:
https://doaj.org/article/c58c279bc2644d58bc3335e889c772da
Autor:
Korakrit Imwattana, Daniel R. Knight, Brian Kullin, Deirdre A. Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V. Riley
Publikováno v:
Emerging Microbes and Infections, Vol 8, Iss 1, Pp 796-807 (2019)
ABSTRACTClostridium difficile ribotype (RT) 017 is an important toxigenic C. difficile RT which, due to a deletion in the repetitive region of the tcdA gene, only produces functional toxin B. Strains belonging to this RT were initially dismissed as n
Externí odkaz:
https://doaj.org/article/f3699d9edda646109ae796d32a636bf6
Autor:
Nikki Y. T. Man, Daniel R. Knight, Scott G. Stewart, Allan J. McKinley, Thomas V. Riley, Katherine A. Hammer
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract The spectrum of activity and mode of action of a novel antibacterial agent, 135C, was investigated using a range of microbiological and genomic approaches. Compound 135C was active against Gram-positive bacteria with MICs for Staphylococcus
Externí odkaz:
https://doaj.org/article/6225b1808d5240eb86f682657bc68d98
Autor:
Muni Kumar Mahadari, Sreenu Jennepalli, Andrew J. Tague, Papanin Putsathit, Melanie L. Hutton, Katherine A. Hammer, Daniel R. Knight, Thomas V. Riley, Dena Lyras, Paul A. Keller, Stephen G. Pyne
Publikováno v:
Antibiotics, Vol 10, Iss 8, p 913 (2021)
Clostridioides (also known as Clostridium) difficile is a Gram-positive anaerobic, spore producing bacterial pathogen that causes severe gastrointestinal infection in humans. The current chemotherapeutic options are inadequate, expensive, and limited
Externí odkaz:
https://doaj.org/article/d7a93aa001934ee6ae056243ed218bbe
Autor:
Papanin Putsathit, Monthira Maneerattanaporn, Pipat Piewngam, Daniel R. Knight, Pattarachai Kiratisin, Thomas V. Riley
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 6, Iss 1, Pp 1-6 (2017)
Abstract Background Exposure to antimicrobials is the major risk factor associated with Clostridium difficile infection (CDI). Paradoxically, treatment of CDI with antimicrobials remains the preferred option. To date, only three studies have investig
Externí odkaz:
https://doaj.org/article/693319add81042c99576788e148abaa1
Autor:
Daniel R. Knight, Thomas V. Riley
Publikováno v:
Frontiers in Public Health, Vol 7 (2019)
Clostridium difficile is toxin-producing antimicrobial resistant (AMR) enteropathogen historically associated with diarrhea and pseudomembranous colitis in hospitalized patients. In recent years, there have been dramatic increases in the incidence an
Externí odkaz:
https://doaj.org/article/7068be3f585043319988f7eddac6872a
Autor:
Daniel R. Knight, Brian Kullin, Grace O. Androga, Frederic Barbut, Catherine Eckert, Stuart Johnson, Patrizia Spigaglia, Kazuhiro Tateda, Pei-Jane Tsai, Thomas V. Riley
Publikováno v:
mBio, Vol 10, Iss 2 (2019)
ABSTRACT Clostridioides difficile (Clostridium difficile) sequence type 11 (ST11) is well established in production animal populations worldwide and contributes considerably to the global burden of C. difficile infection (CDI) in humans. Increasing e
Externí odkaz:
https://doaj.org/article/5d645726104d4943b96cc20c04299f63